Clinical Trial

Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing

Name: Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing — clinical trial record (NCT07743086)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to: * In Phase 1 (observational) to develop an algorithm for treatment of Duffy-null positive patients for chemotherapy dosing * In Phase 2 (interventional), use the algorithm created in phase 1 to adjust chemotherapy dosing for Duffy-null patients

Trial Details

NCT Number	NCT07743086
Lead Sponsor	Barbara Ann Karmanos Cancer Institute
Conditions	Solid Tumor Cancer
Enrollment	886 participants
Start Date	2026-09
Primary Completion	2029-04-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-03